Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
STR-324 by Stragen New Molecules for Post-Operative Pain: Likelihood of Approval
STR-324 is under clinical development by Stragen New Molecules and currently in Phase II for Post-Operative Pain. According to GlobalData,...